Kuan-Gen Huang

Kuan-Gen Huang

Auto-generated profile, based on publicly available information

Kuan-Gen Huang

Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Gynecology and Minimally Invasive Therapy
Verified
Journal Article
Open access
AJAmruta Jaiswal
Amruta Jaiswal
KHKuan-Gen Huang
Kuan-Gen Huang
The introduction of newer vessel sealing systems has revolutionized techniques of hemostasis during laparoscopic surgery. These devices allow for rapid sequential tissue and vessel sealing, coagulation, and transection. Despite of widespread use of newer advanced bipolar and ultrasonic devices, monopolar and conventional bipolar electro-surgery still carry weightage due to wider range of tissue effect, dissection capabilities, cost effectiveness, and ease of availability. Here in we discussed different types of commonly available energy sources in terms of mechanism, efficacy and safety as thorough knowledge is utmost important for surgeon to choose appropriate instrument for surgical procedure.

1 February 2018 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
CLChyi-Long Lee
Chyi-Long Lee
SKSoshi Kusunoki
Soshi Kusunoki
CHChen-Yin Huang
Chen-Yin Huang
KWKai-Yun Wu
Kai-Yun Wu
PLPei-Shan Lee
Pei-Shan Lee
KHKuan-Gen Huang
Kuan-Gen Huang
To assess the feasibility and survival outcomes of laparoscopic staging for patients with stage I ovarian cancer. Consecutive patients who underwent laparoscopic staging surgery for stage I ovarian cancer from January 2002 to December 2014 were evaluated retrospectively by chart review. Twenty-four patients with mean age 43.9 ± 9.9 years and mean body mass index 24.0 ± 3.8 kg/m2 were included, in which 12 (50%) patients were in stage IA and 12 (50%) in stage IC. The histological types included serous in 6 (25%), mucinous in 7 (29.1%), endometrioid in 6 (25%), clear cell in 5 (20.8%) patients. The mean surgical time was 306.4 ± 98.5 min, and the mean blood loss was 204.2 ± 188.6 mL. None of the patients required conversion to laparotomy. The median numbers of resected pelvic and para-aortic lymph nodes were 20 and 4, respectively. One (4.1%) patient encountered bowel injury intraoperatively, and the other 1 (4.1%) patient hydronephrosis postoperatively. The overall survival rate was 95% in the current series in a median follow-up of 31.5 months. Laparoscopic staging surgery performed for early stage ovarian cancer has better long term survival outcomes than the literature report. Laparoscopic treatment by a trained gynecologic oncologist is an ideal alternative for early stage ovarian cancer with the advantage of minimal invasiveness.

1 December 2015 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
HSHsuan Su
Hsuan Su
LHLulu Huang
Lulu Huang
KHKuan-Gen Huang
Kuan-Gen Huang
CYChih-Feng Yen
Chih-Feng Yen
CHChien-Min Han
Chien-Min Han
CLChiyi-Long Lee
Chiyi-Long Lee
To compare the methods of transcervical resectoscopy versus dilation and curettage (D&C) for endometrial biopsy and to compare these methods for the percentage of histological upgrades at the final posthysterectomy pathology findings in endometrial cancer. We retrospectively reviewed 253 cases of uterine cancer diagnosed from May 1995 to January 2014. Included in the study were patients who received transcervical resectoscopy (TCR) or D&C biopsy as the diagnostic method and underwent laparoscopic staging at our institution. The International Federation of Gynecologists and Obstetricians (FIGO) grade in the pathological report of the biopsy and final hysterectomy were recorded. The extrauterine risk was stratified using the initial FIGO grade and depth of myometrium invasion. It was compared to the actual risk using final pathological findings. We identified 203 cases of endometrial cancer; 18 (8.9%) patients had a higher histological grade at the final hysterectomy. Among the 203 patients, 76 patients underwent TCR biopsy and 127 underwent D&C biopsy. The histological grade was upgraded in two (2.6%) patients in the TCR group. Three (3.9%) patients had positive peritoneal washings. In the D&C group, 16 (12.6%) patients with three (2.4%) positive peritoneal washings were upgraded. Transcervical resectoscopy could provide more precise grading information, compared to D&C (2.6% vs. 12.6%). Doctors could therefore make a more accurate staging plan, based on the preoperative risk evaluation.

1 August 2016 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
CLChyi-Long Lee
Chyi-Long Lee
SKSoshi Kusunoki
Soshi Kusunoki
KHKuan-Gen Huang
Kuan-Gen Huang
KWKai-Yun Wu
Kai-Yun Wu
CHChen-Yin Huang
Chen-Yin Huang
CYChih-Feng Yen
Chih-Feng Yen
To assess the long-term outcomes of laparoscopic staging surgery (LSS) in treating patients with endometrial carcinoma.Patients with endometrial cancer who underwent LSS between June 1995 and June 2014 were prospectively registered. Perioperative data, complications, disease recurrence, and long-term survival were measured.The study included 287 consecutive patients [mean age (± standard deviation), 53±10.4 years; mean body mass index, 27.3±6.7 kg/m(2)] with a median follow-up ranging from 1 to 216 months. No laparotomy conversion was recorded for any patient. The mean operative time was 207±63.5 minutes, and the mean blood loss was 183±166.7 mL. The mean numbers of pelvic nodes and para-aortic nodes removed were 18±4.8 and 8±5, respectively. More than 80% of the patients had an International Federation of Gynecology and Obstetrics (FIGO) Stage 1 disease. The overall complication rate was 3.1%, including two patients of bladder injuries and one with bowel injury intraoperatively, and postoperatively one patient with pelvic abscess, three with urinary tract infection, one with voiding difficulty, and one with bowel perforation. The overall survival rates were 94% in 5 years and 92.7% in 20 years. No port-site metastasis was recorded in this study.Patients with endometrial carcinoma treated by LSS had compatible or even better long-term survival outcomes and less complication in comparison with the published data, in addition to the benefits of its minimally invasive characteristics. LSS should be the treatment of choice for endometrial cancer.

1 September 2014 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
HPHsiu-Huei Peng
Hsiu-Huei Peng
KHKuan-Gen Huang
Kuan-Gen Huang
HCHo-Yen Chueh
Ho-Yen Chueh
AAAizura Syafinaz Ahmad Adlan
Aizura Syafinaz Ahmad Adlan
SCShuenn-Dyn Chang
Shuenn-Dyn Chang
CLChyi-Long Lee
Chyi-Long Lee

1 November 2002 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
CLChao‐Hsi Lee
Chao‐Hsi Lee
KHKuan‐General Huang
Kuan‐General Huang
SUShir‐Hwa Ueng
Shir‐Hwa Ueng
HSHsueh Swei
Hsueh Swei
HCHo‐Yen Chueh
Ho‐Yen Chueh
CLChyong‐Huey Lai
Chyong‐Huey Lai
Click on the article title to read more.